oxazoles has been researched along with Adverse Drug Event in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Califf, RM; Demets, D; George, JT; Gerstein, HC; Granger, C; Green, JB; Hobbs, T; Holman, RR; Lawson, FC; Leiter, LA; McGuire, DK; McMurray, J; Pagidipati, NJ; Pfeffer, MA; Reusch, J; Riesmeyer, JS; Roe, MT; Rosenberg, Y; Sharma, A; Temple, R; Wiviott, S | 1 |
Hwang, SH; Jeon, D; Kang, B; Kang, H; Koh, WJ; Lee, T; Mok, J; Park, JS; Yim, JJ | 1 |
Alyea, RA; Gollapudi, BB; Rasoulpour, RJ | 1 |
Das, D; Fang, E; Mehra, P; Prokocimer, P; Tulkens, PM | 1 |
Arrieta, AC; Bradley, JS; Capparelli, E; Flanagan, SD; Jacobs, R; Prokocimer, P | 1 |
Chen, YC; Wu, YH | 1 |
An, Y; Blanar, MA; Bolton, SA; Cap, M; Chang, C; Chen, BC; Chen, S; Chen, SY; Cheng, PT; Devasthale, PV; Grimm, D; Harrity, T; Hernández, AS; Hosagrahara, V; Kadiyala, P; Kennedy, LJ; Krystek, SR; Kunselman, LK; Lai, Z; Li, J; Li, YX; Lim, NK; Locke, KT; Meyers, DS; Miao, B; Monshizadegan, H; Muckelbauer, JK; Mukherjee, R; O'Malley, KM; Ryono, DE; Search, D; Shi, Y; Smirk, RA; Srivastava, RA; Tao, S; Tino, JA; Wang, W; Wang, Y; Wu, S; Xu, C; Ye, XY; Zahler, R; Zhang, H; Zhang, L; Zhang, R | 1 |
Finkelstein, JB | 1 |
Lewit, T | 1 |
Ratzenhofer, M | 1 |
2 review(s) available for oxazoles and Adverse Drug Event
Article | Year |
---|---|
Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: safety summary.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Humans; Organophosphates; Oxazoles; Staphylococcal Skin Infections | 2014 |
[Pulmonary diseases due to drugs. II].
Topics: Amines; Amitriptyline; Beclomethasone; Drug-Related Side Effects and Adverse Reactions; Heroin; Humans; Hydantoins; Lung Diseases; Methadone; Naloxone; Oxazoles; Pneumonia, Aspiration; Respiratory Therapy; Sulfasalazine; Ventilators, Mechanical | 1974 |
1 trial(s) available for oxazoles and Adverse Drug Event
Article | Year |
---|---|
Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Anti-Bacterial Agents; Bacterial Infections; Biological Availability; Blood Chemical Analysis; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Urine | 2016 |
7 other study(ies) available for oxazoles and Adverse Drug Event
Article | Year |
---|---|
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Glucose; Glycated Hemoglobin; Glycine; Government Regulation; Humans; Hypoglycemic Agents; Oxazoles; Phenylbutazone; Practice Guidelines as Topic; Risk; Rosiglitazone; Tolbutamide; United States; United States Food and Drug Administration | 2020 |
Interim outcomes of delamanid for the treatment of MDR- and XDR-TB in South Korea.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacteriological Techniques; Drug-Related Side Effects and Adverse Reactions; Female; Hospitals; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Republic of Korea; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2018 |
Are we ready to consider transgenerational epigenetic effects in human health risk assessment?
Topics: Animals; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Epigenesis, Genetic; Epigenomics; Female; Humans; Maternal Exposure; Models, Animal; No-Observed-Adverse-Effect Level; Oxazoles; Phenotype; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Rats; Risk Assessment | 2014 |
Linear Folliculotropic CD30-Positive Lymphomatoid Drug Reaction.
Topics: Biopsy, Needle; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Facial Dermatoses; Female; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphocytes; Lymphoma, T-Cell, Cutaneous; Middle Aged; Oxazoles; Risk Assessment; Skin Neoplasms; Withholding Treatment | 2017 |
Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453).
Topics: Animals; Cell Line; Cricetinae; Crystallography, X-Ray; Drug Discovery; Drug-Related Side Effects and Adverse Reactions; Glycine; Humans; Male; Mice; Models, Molecular; Oxazoles; PPAR alpha; Protein Structure, Tertiary; Substrate Specificity; Transcriptional Activation | 2010 |
Drug safety system needs overhaul, experts say.
Topics: Cardiovascular Diseases; Conflict of Interest; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Glycine; Heart; Humans; Journalism, Medical; Oxazoles; Peroxisome Proliferator-Activated Receptors; Publication Bias; United States; United States Food and Drug Administration | 2006 |
[Side-effects and fatal outcome of drug therapy. Pathological and anatomical experiences during the past 18 years in Styrial].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Amines; Analgesics; Anaphylaxis; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anticoagulants; Anticonvulsants; Appetite Depressants; Austria; Autopsy; Child; Contraceptives, Oral; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Oxazoles; Retrospective Studies; Tolbutamide; Tranquilizing Agents | 1972 |